HARSHADKUMAR PATEL: Open Payments
NPI 1952568008 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,575 in 75 payments from 18 companies in 2025. Trend: 2023 $985 · 2024 $1,725 · 2025 $1,575
Food & beverage: $1,575
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $292 |
| Neurocrine BioSciences, Inc. | 13 | $237 |
| E.R. Squibb & Sons, L.L.C. | 9 | $191 |
| Supernus Pharmaceuticals, Inc. | 9 | $164 |
| Noven Therapeutics, LLC | 7 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Alkermes, Inc. | 3 | $54 |
Products named: VRAYLAR, INGREZZA, COBENFY, Qelbree, Xelstrym, TRINTELLIX, REXULTI, Auvelity.
Industry payments across FL — which companies pay providers there.
